Molecular Partners (MOLN) Income Statement

44 Followers

Molecular Partners Income Statement

Last quarter (Q4 2025), Molecular Partners's total revenue was CHF0.00, a decrease of ― from the same quarter last year. In Q4, Molecular Partners's net income was CHF-12.65M. See Molecular Partners’s key income statements, including revenue, expenses, profit, and income.

Income Statement	Dec 25	Dec 24	Dec 23	Dec 22	Dec 21
Total Revenue	CHF 0.00	CHF 4.97M	CHF 7.04M	CHF 189.56M	CHF 9.33M
Gross Profit	CHF 0.00	CHF -42.53M	CHF -40.81M	CHF 138.81M	CHF -46.39M
Operating Expenses	CHF 58.12M	CHF 18.68M	CHF 20.30M	CHF 72.94M	CHF 72.75M
Depreciation and Amortization	CHF 2.14M	CHF 2.37M	CHF 2.42M	CHF 2.39M	CHF 2.56M
EBITDA	CHF -59.49M	CHF -51.65M	CHF -59.52M	CHF 119.00M	CHF -60.66M
Operating Income	CHF -58.12M	CHF -61.22M	CHF -61.11M	CHF 116.61M	CHF -63.42M
Other Income/Expenses	CHF -3.52M	CHF 7.18M	CHF -876.00K	CHF 1.24M	CHF -365.00K
Pretax Income	CHF -61.65M	CHF -54.04M	CHF -61.98M	CHF 117.85M	CHF -63.78M
Net Income	CHF -61.65M	CHF -54.04M	CHF -61.98M	CHF 117.85M	CHF -63.78M
Per Share Metrics
Basic EPS	CHF -1.65	CHF -1.59	CHF -1.89	CHF 3.63	CHF -2.06
Diluted EPS	CHF -1.65	CHF -1.59	CHF -1.89	CHF 3.54	CHF -2.06
Weighted Average Shares Outstanding	37.27M	34.03M	32.77M	32.47M	31.01M
Weighted Average Shares Outstanding (Diluted)	37.27M	34.03M	32.77M	33.27M	31.01M

Currency in CHF

Molecular Partners (MOLN) Income Statement

Molecular Partners Income Statement

Molecular Partners Earnings and Revenue History